We observed that cancers were sometimes diagnosed in anti-CCAR1–positive patients (10 in the Johns Hopkins cohort, 8 in the Stanford cohort), and wondered whether these cancers have similar timing of diagnosis and cancer stage as those cancers diagnosed in anti–TIF1-γ–only DM patients. This evidence concerns the gene TRIM33 and dermatomyositis.